Atara Biotherapeutics experiences a plunge in share prices after the Food and Drug Administration holds up approval of a drug candidate. Atara Biotherapeutics' headquarters in Thousand Oaks. The share ...

Tuesday, H.C. Wainwright maintained its Neutral stance on Atara Biotherapeutics stock (NASDAQ:ATRA), following the company's announcement of a significant workforce reduction. According to ...

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to ...

Atara Biotherapeutics experiences a plunge in share prices after the Food and Drug Administration holds up approval of a drug candidate. Atara Biotherapeutics' headquarters in Thousand Oaks. The ...

Atara Biotherapeutics (NASDAQ:ATRA) has announced plans to cut around 50% of its workforce, just a little over a week after it said the FDA had declined to approve its immunotherapy Ebvallo. The ...

As of Tuesday, the Wyatt Detention Facility reported holding 706 federal detainees, representing about 91% of the 770-bed facility’s capacity. The quasi-public jail is considered full even if ...

Shares of Atara Biotherapeutics (ATRA) have gained 11.4% over the past four weeks to close the last trading session at $8.72, but there could still be a solid upside left in the stock if short ...

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Atara Biotherapeutics, Inc. ("Atara" or "the Company") (NASDAQ:ATRA). Investors who purchased Atara ...

It's been almost two months since The Wyatt Sicks was seen on WWE television. During their time away from the ring, the group was moved to "WWE SmackDown" thanks to the company's transfer portal ...

The Wyatt Sicks haven't been seen on WWE TV for several weeks and in their time away they have been moved from RAW to SmackDown. The group is yet to appear on the blue brand, but it seems that ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...